RGNX
Price
$8.44
Change
+$0.20 (+2.43%)
Updated
Jul 16, 02:41 PM (EDT)
Capitalization
415.2M
14 days until earnings call
SEER
Price
$2.10
Change
-$0.00 (-0.00%)
Updated
Jul 16, 11:12 AM (EDT)
Capitalization
123.58M
22 days until earnings call
Interact to see
Advertisement

RGNX vs SEER

Header iconRGNX vs SEER Comparison
Open Charts RGNX vs SEERBanner chart's image
REGENXBIO
Price$8.44
Change+$0.20 (+2.43%)
Volume$180
Capitalization415.2M
Seer
Price$2.10
Change-$0.00 (-0.00%)
Volume$600
Capitalization123.58M
RGNX vs SEER Comparison Chart in %
Loading...
RGNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SEER
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
RGNX vs. SEER commentary
Jul 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RGNX is a Hold and SEER is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 16, 2025
Stock price -- (RGNX: $8.24 vs. SEER: $2.10)
Brand notoriety: RGNX and SEER are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: RGNX: 45% vs. SEER: 38%
Market capitalization -- RGNX: $415.2M vs. SEER: $123.58M
RGNX [@Biotechnology] is valued at $415.2M. SEER’s [@Biotechnology] market capitalization is $123.58M. The market cap for tickers in the [@Biotechnology] industry ranges from $308.32B to $0. The average market capitalization across the [@Biotechnology] industry is $2.45B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

RGNX’s FA Score shows that 0 FA rating(s) are green whileSEER’s FA Score has 0 green FA rating(s).

  • RGNX’s FA Score: 0 green, 5 red.
  • SEER’s FA Score: 0 green, 5 red.
According to our system of comparison, both RGNX and SEER are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

RGNX’s TA Score shows that 3 TA indicator(s) are bullish while SEER’s TA Score has 4 bullish TA indicator(s).

  • RGNX’s TA Score: 3 bullish, 7 bearish.
  • SEER’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, SEER is a better buy in the short-term than RGNX.

Price Growth

RGNX (@Biotechnology) experienced а -2.25% price change this week, while SEER (@Biotechnology) price change was -3.23% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.65%. For the same industry, the average monthly price growth was +10.09%, and the average quarterly price growth was +39.04%.

Reported Earning Dates

RGNX is expected to report earnings on Nov 05, 2025.

SEER is expected to report earnings on Nov 11, 2025.

Industries' Descriptions

@Biotechnology (+2.65% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RGNX($415M) has a higher market cap than SEER($124M). RGNX YTD gains are higher at: 6.598 vs. SEER (-9.091). SEER has higher annual earnings (EBITDA): -89.36M vs. RGNX (-122.44M). RGNX has more cash in the bank: 268M vs. SEER (240M). SEER has less debt than RGNX: SEER (25.4M) vs RGNX (79.8M). RGNX has higher revenues than SEER: RGNX (157M) vs SEER (15.1M).
RGNXSEERRGNX / SEER
Capitalization415M124M335%
EBITDA-122.44M-89.36M137%
Gain YTD6.598-9.091-73%
P/E RatioN/AN/A-
Revenue157M15.1M1,040%
Total Cash268M240M112%
Total Debt79.8M25.4M314%
FUNDAMENTALS RATINGS
RGNX: Fundamental Ratings
RGNX
OUTLOOK RATING
1..100
3
VALUATION
overvalued / fair valued / undervalued
1..100
50
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
53
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
RGNXSEER
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
87%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
84%
Bullish Trend 2 days ago
86%
Momentum
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
86%
MACD
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 2 days ago
79%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
88%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
89%
Advances
ODDS (%)
Bullish Trend 8 days ago
76%
Bullish Trend 14 days ago
76%
Declines
ODDS (%)
Bearish Trend 6 days ago
84%
Bearish Trend 9 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
86%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
RGNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SEER
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NONOF67.140.13
+0.19%
Novo-Nordisk A/S
BETRF0.07N/A
N/A
BETTERLIFE PHARMA INC.
NBBTF0.05N/A
N/A
Natural Beauty Biotechnology Ltd.
ZLDSF30.51N/A
N/A
ZALANDO SE
ARSSF0.67-0.02
-2.97%
Assura Plc